US 6117836
Glycosylation-mediated inhibition of factor X
expired A61KA61K38/1709A61K38/47
Quick answer
US patent 6117836 (Glycosylation-mediated inhibition of factor X) held by COR Therapeutics, Inc. expires Mon Sep 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- COR Therapeutics, Inc.
- Grant date
- Tue Sep 12 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K38/1709, A61K38/47, A61P, A61P29/00